- Home
- ABEO vs AVNW Comparison
ABEO vs AVNW Comparison
Compare ABEO & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | AVNW |
|---|---|---|
| Founded | 1974 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.2M | 275.0M |
| IPO Year | 2005 | 2007 |
Fundamental Metrics
Financial Performance| Metric | ABEO | AVNW |
|---|---|---|
| Price | $5.12 | $24.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $18.20 | ★ $34.67 |
| AVG Volume (30 Days) | ★ 924.3K | 104.4K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.74 | N/A |
| EPS | ★ 1.35 | 0.45 |
| Revenue | $2,998,000.00 | ★ $243,858,000.00 |
| Revenue This Year | N/A | $5.59 |
| Revenue Next Year | $1,589.77 | $7.03 |
| P/E Ratio | ★ $3.60 | $55.71 |
| Revenue Growth | ★ 258.18 | 0.56 |
| 52 Week Low | $3.93 | $15.84 |
| 52 Week High | $7.54 | $27.02 |
Technical Indicators
Market Signals| Indicator | ABEO | AVNW |
|---|---|---|
| Relative Strength Index (RSI) | 50.64 | 53.72 |
| Support Level | $4.87 | $20.93 |
| Resistance Level | $5.60 | $26.51 |
| Average True Range (ATR) | 0.21 | 1.00 |
| MACD | -0.02 | -0.08 |
| Stochastic Oscillator | 44.84 | 38.41 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About AVNW Aviat Networks Inc.
Aviat Networks Inc provides wireless transport and access networking solutions designed to support telecommunications operators and private network providers situated in various countries. The company offers a range of microwave and millimeter wave radios, network management tools, and services that enable high-capacity, secure, and reliable data transport over wireless networks. Its products serve diverse clients including mobile operators, public safety organizations, utilities, government agencies, and enterprise customers. Aviat generates revenue from the sale of its networking equipment, professional services, and ongoing support contracts. Its operations cover various regions including the Americas, Europe, Asia Pacific, the Middle East, and Africa.